Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Change in Cash (2016 - 2025)

HealthLynked (HLYK) has disclosed Change in Cash for 10 consecutive years, with -$9290.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 94.11% to -$9290.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$4047.0, a 88.87% increase, with the full-year FY2024 number at -$170981.0, down 192.26% from a year prior.
  • Change in Cash was -$9290.0 for Q3 2025 at HealthLynked, down from -$2069.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $3.2 million in Q1 2021 to a low of -$2.2 million in Q4 2021.
  • A 5-year average of -$7961.7 and a median of -$53971.0 in 2025 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: soared 3288.8% in 2021, then tumbled 3402.3% in 2024.
  • HealthLynked's Change in Cash stood at -$2.2 million in 2021, then soared by 95.54% to -$96269.0 in 2022, then surged by 303.49% to $195894.0 in 2023, then crashed by 68.72% to $61283.0 in 2024, then plummeted by 115.16% to -$9290.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Change in Cash are -$9290.0 (Q3 2025), -$2069.0 (Q2 2025), and -$53971.0 (Q1 2025).